title: Effect of Scopolamine Patch Use on Postoperative Voiding Function After Transobturator Slings.
abstract: The aim of this study was to determine whether the use of a preoperative transdermal scopolamine (TDS) patch for postoperative nausea and vomiting prophylaxis affects the success of a voiding trial after a transobturator tape sling procedure.
  
  
  
  This study is a retrospective cohort study of adult women who underwent a transobturator tape sling procedure without concomitant procedures from February 1, 2009 through August 1, 2010. The exposed group included all eligible women who received a preoperative TDS patch. For each exposed woman, we selected the next 2 consecutive eligible women who did not receive a TDS patch to be included in the unexposed group. The primary outcome was postoperative voiding trial failure.
  
  
  
  We identified 35 women who met eligibility criteria and used a preoperative TDS patch, and included 70 women who did not use a preoperative TDS. A significantly higher proportion of women in the TDS patch group (54.3%) failed their voiding trial than in the group that did not receive TDS (7.1%, P ≤ 0.001). A history of an incontinence procedure, older age, and higher body mass index strengthened the association between TDS patch and voiding trial failure. The adjusted model yielded a risk ratio for voiding trial failure of 13.8 (95% confidence interval, 5.2-36.5) for women who received TDS patch compared with those who did not.
  
  
  
  The results of this study demonstrate that use of TDS patches for postoperative nausea and vomiting prophylaxis may negatively affect the success of voiding trials after transobturator tape sling procedures.
authors.affiliation: From the *Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center; †Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston; and ‡Department of Obstetrics and Gynecology, Mount Auburn Hospital, Cambridge, MA.
authors.forename: Sybil G
authors.initials: SG
authors.lastname: Dessie
authors.forename: Michele R
authors.initials: MR
authors.lastname: Hacker
authors.forename: Costas
authors.initials: C
authors.lastname: Apostolis
authors.forename: Ellen O
authors.initials: EO
authors.lastname: Boundy
authors.forename: Anna M
authors.initials: AM
authors.lastname: Modest
authors.forename: Stephanie-Marie L
authors.initials: SM
authors.lastname: Jones
authors.forename: Peter L
authors.initials: PL
authors.lastname: Rosenblatt
mesh_terms: D000279:Administration, Cutaneous; D000328:Adult; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control; D011184:Postoperative Period; D057234:Preoperative Period; D012189:Retrospective Studies; D012601:Scopolamine / Q000008:administration & dosage / Q000009:adverse effects*; D053825:Suburethral Slings; D001743:Urinary Bladder / Q000187:drug effects*; D014550:Urinary Incontinence, Stress / Q000601:surgery*; D014554:Urination / Q000187:drug effects*
chemical_list: D018727:Muscarinic Antagonists; D012601:Scopolamine
references.citation: Obstet Gynecol. 2014 Jun;123(6):1201-6
references.pmid: 24807341
references.citation: Surg Endosc. 2015 Nov;29(11):3140-5
references.pmid: 25552230
references.citation: Eur Urol. 2003 Dec;44(6):724-30
references.pmid: 14644127
references.citation: Eur Urol. 2007 Mar;51(3):782-7; discussion 787
references.pmid: 17098355
references.citation: Eur J Anaesthesiol. 2011 Mar;28(3):190-4
references.pmid: 21206278
references.citation: Urology. 1986 Nov;28(5):440-5
references.pmid: 3787914
references.citation: Minerva Ginecol. 2009 Apr;61(2):167-72
references.pmid: 19255563
references.citation: Arch Surg. 2008 Jun;143(6):551-7
references.pmid: 18559747
references.citation: Female Pelvic Med Reconstr Surg. 2014 May-Jun;20(3):163-7
references.pmid: 24763158
references.citation: Am J Obstet Gynecol. 2007 Dec;197(6):627.e1-4
references.pmid: 18060956
references.citation: Anesth Analg. 2009 May;108(5):1498-504
references.pmid: 19372328
references.citation: Int Urogynecol J. 2011 Nov;22(11):1437-43
references.pmid: 21975533
references.citation: Clin Ther. 2010 Nov;32(12):1987-2002
references.pmid: 21118734
references.citation: Front Pharmacol. 2014 Apr 09;5:55
references.pmid: 24782768
references.citation: Female Pelvic Med Reconstr Surg. 2015 Sep-Oct;21(5):257-62
references.pmid: 25521470
references.citation: Anesth Analg. 2005 Aug;101(2):592-6, table of contents
references.pmid: 16037182
references.citation: Rev Urol. 2004;6 Suppl 3:S3-9
references.pmid: 16985863
references.citation: Curr Urol Rep. 2005 Sep;6(5):356-9
references.pmid: 16120236
references.citation: Am J Obstet Gynecol. 2002 Jul;187(1):49-52
references.pmid: 12114887
references.citation: J Urol. 2008 Nov;180(5):2076-80
references.pmid: 18804239
references.citation: Am J Obstet Gynecol. 2006 Dec;195(6):1820-5
references.pmid: 17027591
references.citation: Am J Obstet Gynecol. 2014 Jul;211(1):71.e1-71.e27
references.pmid: 24487005
references.citation: BJU Int. 2004 Jul;94(1):110-3
references.pmid: 15217442
references.citation: Anesthesiology. 2009 May;110(5):1139-57
references.pmid: 19352147
references.citation: Int Urogynecol J. 2010 Dec;21(12):1491-8
references.pmid: 20585756
references.citation: Eur Urol. 2014 Jun;65(6):1109-14
references.pmid: 24508070
references.citation: Curr Urol Rep. 2005 Sep;6(5):365-70
references.pmid: 16120239
references.citation: Obstet Gynecol. 2012 Jul;120(1):83-90
references.pmid: 22914395
references.citation: Prog Urol. 2001 Dec;11(6):1306-13
references.pmid: 11859672
references.citation: Ther Drug Monit. 2005 Oct;27(5):655-65
references.pmid: 16175141